Who owns BioMarin Pharmaceutical?
- Ticker: BMRN
- CUSIP Number: 09061G101
Tip: Access positions for across all investors
Analyze quarterly positions in BioMarin Pharmaceutical with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of BioMarin Pharmaceutical stock
Who bought or sold BioMarin Pharmaceutical this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 20M | $1.1B | 4% | Mar 2026 |
|
| Dodge & Cox | 15M | $823M | 0% | Mar 2026 |
|
| PRIMECAP Management Company | 14M | $802M | -2% | Mar 2026 |
|
| Vanguard Capital Management | 8.6M | $488M | 100% | Mar 2026 |
|
| Vanguard Portfolio Management | 8.3M | $469M | 100% | Mar 2026 |
|
| AQR Capital Management | 7.7M | $429M | 15% | Mar 2026 |
|
| State Street Corporation | 7.3M | $412M | -3% | Mar 2026 |
|
| Viking Global Investors | 7.1M | $399M | 17% | Mar 2026 |
|
| Citadel Advisors | 4.7M | $265M | 180% | Mar 2026 |
|
| Geode Capital Management | 3.8M | $216M | 4% | Mar 2026 |
|
| Dimensional Fund Advisors | 3.8M | $215M | 14% | Mar 2026 |
|
| Vestal Point Capital | 3.6M | $202M | 19% | Mar 2026 |
|
| FMR | 3.6M | $202M | 94% | Mar 2026 |
|
| Capital Research Global Investors | 3.5M | $197M | 37% | Mar 2026 |
|
| Millennium Management | 3.1M | $173M | -5% | Mar 2026 |
|
| UBS Group | 1.9M | $109M | -21% | Mar 2026 |
|
| Assenagon Asset Management | 1.8M | $101M | -8% | Jun 2026 |
|
| First Trust Advisors | 1.7M | $95M | 43% | Mar 2026 |
|
| Charles Schwab Investment Management | 1.6M | $90M | 12% | Mar 2026 |
|
| Northern Trust | 1.6M | $90M | 2% | Mar 2026 |
|
| Balyasny Asset Management | 1.4M | $77M | 14875% | Mar 2026 |
|
| Morgan Stanley | 1.3M | $75M | -43% | Mar 2026 |
|
| Point72 Asset Management | 1.3M | $73M | 196% | Mar 2026 |
|
| Jones Hill Capital | 1.3M | $72M | 100% | Mar 2026 |
|
| DnB NOR Asset Management AS | 1.2M | $69M | -10% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 1.2M | $68M | 100% | Mar 2026 |
|
| Pictet Asset Management Holding SA | 1.2M | $67M | -7% | Mar 2026 |
|
| Ameriprise Financial | 1.2M | $66M | -20% | Mar 2026 |
|
| Susquehanna International | 1.2M | $66M | -20% | Mar 2026 |
|
| Deep Track Capital | 1.2M | $65M | -50% | Mar 2026 |
|
| Bank of New York Mellon | 1.1M | $65M | -7% | Mar 2026 |
|
| Renaissance Technologies | 1.0M | $58M | -23% | Mar 2026 |
|
| Hudson Bay Capital Management | 975k | $55M | 45% | Mar 2026 |
|
| Caisse de depot et placement du Quebec | 946k | $53M | -10% | Mar 2026 |
|
| Bank of America Corporation | 937k | $53M | 100% | Mar 2026 |
|
| Franklin Resources | 934k | $53M | 882% | Mar 2026 |
|
| LSV Asset Management | 885k | $50M | 0% | Mar 2026 |
|
| Henderson Group | 857k | $48M | 100% | Mar 2026 |
|
| Deerfield Management Company | 852k | $48M | 100% | Mar 2026 |
|
| Ubs Global Asset Management Americas | 851k | $48M | 33% | Mar 2026 |
|
| Swedbank AB | 792k | $45M | -1% | Mar 2026 |
|
| Sofinnova Ventures | 782k | $44M | 12% | Mar 2026 |
|
| Wellington Management Company | 717k | $41M | -9% | Mar 2026 |
|
| Fort Washington Investment Advisors | 716k | $41M | 0% | Jun 2026 |
|
| Loomis, Sayles and | 714k | $40M | 0% | Mar 2026 |
|
| Nuveen | 705k | $40M | 4% | Mar 2026 |
|
| Qube Research & Technologies | 690k | $39M | -52% | Mar 2026 |
|
| Edmond De Rothschild Holding | 686k | $39M | 3% | Mar 2026 |
|
| Palo Alto Investors | 685k | $39M | -8% | Mar 2026 |
|
| Novo A/S | 660k | $37M | 0% | Mar 2026 |
|
| Soleus Capital Management | 651k | $37M | -51% | Mar 2026 |
|
| Thrivent Financial for Lutherans | 628k | $36M | -21% | Mar 2026 |
|
| Russell Investments | 606k | $34M | -29% | Mar 2026 |
|
| Freestone Grove Partners | 606k | $34M | 23% | Mar 2026 |
|
| Legal & General Group | 575k | $33M | -5% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 575k | $33M | 8% | Mar 2026 |
|
| Boone Capital Management | 548k | $31M | 33% | Mar 2026 |
|
| River Road Asset Management | 543k | $31M | -41% | Jun 2026 |
|
| Krensavage Asset Management | 525k | $30M | 0% | Mar 2026 |
|
| Rhumbline Advisers | 522k | $30M | 2% | Mar 2026 |
|
| Eagle Health Investments | 506k | $29M | 38% | Mar 2026 |
|
| Braidwell | 497k | $28M | -17% | Mar 2026 |
|
| CalPERS | 491k | $28M | -7% | Mar 2026 |
|
| Leucadia National Corporation | 468k | $26M | 0% | Mar 2026 |
|
| Citigroup | 454k | $26M | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 449k | $25M | 3% | Mar 2026 |
|
| Mackenzie Financial | 441k | $25M | 18% | Mar 2026 |
|
| Rubric Capital Management | 441k | $25M | 100% | Mar 2026 |
|
| Engineers Gate Manager | 437k | $25M | 17% | Mar 2026 |
|
| Principal Financial Group | 429k | $24M | 4% | Mar 2026 |
|
| Invesco | 419k | $24M | -8% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 411k | $23M | -40% | Mar 2026 |
|
| Robeco Institutional Asset Management B V | 408k | $23M | -25% | Jun 2026 |
|
| Thomas Stevens, CFA" | 407k | $23M | -63% | Mar 2026 |
|
| Walleye Trading Advisors | 404k | $23M | 51% | Mar 2026 |
|
| Ieq Capital | 402k | $23M | 12% | Mar 2026 |
|
| Allianz Asset Management | 400k | $23M | 10% | Mar 2026 |
|
| Goldman Sachs Group | 380k | $21M | -17% | Mar 2026 |
|
| Rockefeller Capital Management | 372k | $21M | 3% | Mar 2026 |
|
| Swiss National Bank | 361k | $20M | 0% | Mar 2026 |
|
| Squarepoint Ops | 360k | $20M | -80% | Mar 2026 |
|
| Raymond James Financial | 331k | $19M | 57% | Mar 2026 |
|
| Levin Easterly Partners | 329k | $19M | 33% | Jun 2026 |
|
| Lazard Asset Management | 326k | $18M | -4% | Mar 2026 |
|
| LMR Partners | 325k | $18M | 1594% | Mar 2026 |
|
| Man Group | 310k | $18M | -14% | Mar 2026 |
|
| SEB Asset Management AB | 293k | $17M | 100% | Mar 2026 |
|
| D. E. Shaw & Co | 283k | $16M | -73% | Mar 2026 |
|
| DekaBank Deutsche Girozentrale | 280k | $16M | 0% | Mar 2026 |
|
| Mariner Wealth Advisors | 269k | $15M | 54% | Mar 2026 |
|
| CAM Group Holding A/S | 268k | $15M | 0% | Mar 2026 |
|
| Caption Management | 265k | $15M | 1258% | Mar 2026 |
|
| HPM Partners | 263k | $15M | 0% | Mar 2026 |
|
| Systematic Financial Management | 255k | $14M | 0% | Mar 2026 |
|
| Sei Investments | 252k | $14M | -9% | Mar 2026 |
|
| Alliancebernstein | 248k | $15M | -6% | Mar 2026 |
|
| Motley Fool Wealth Management | 248k | $14M | -25% | Mar 2026 |
|
| Sector Gamma ASA | 240k | $14M | 21% | Mar 2026 |
|
| Retirement Systems of Alabama | 236k | $13M | 2% | Mar 2026 |
|
| Canada Pension Plan Investment Board | 230k | $13M | -61% | Mar 2026 |
|
| M&G | 227k | $13M | 1% | Mar 2026 |
|
| California State Teachers Retirement System | 215k | $12M | 24% | Mar 2026 |
|
| CIBC Bancorp USA | 208k | $12M | 100% | Mar 2026 |
|
| Eversept Partners | 208k | $12M | 122% | Mar 2026 |
|
| Rhenman & Partners Asset Management AB | 207k | $12M | -4% | Mar 2026 |
|
| Bridgewater Associates | 207k | $12M | -10% | Mar 2026 |
|
| Capital Fund Management | 195k | $11M | -29% | Mar 2026 |
|
| Sio Capital Management | 194k | $11M | -17% | Mar 2026 |
|
| Amundi | 189k | $11M | -5% | Mar 2026 |
|
| Van Eck Associates Corp. | 182k | $10M | 25% | Mar 2026 |
|
| T. Rowe Price Associates | 176k | $14M | 12% | Mar 2026 |
|
| Gotham Asset Management | 174k | $9.8M | -35% | Mar 2026 |
|
| Redmile Group | 174k | $9.8M | 100% | Mar 2026 |
|
| Vanguard Asset Management | 172k | $9.7M | 100% | Mar 2026 |
|
| Algert Coldiron Investors | 167k | $9.4M | 42% | Mar 2026 |
|
| Nomura Asset Management International | 164k | $9.2M | 100% | Mar 2026 |
|
| Peregrine Capital Management | 163k | $9.3M | 11% | Jun 2026 |
|
| Florida State Board of Administration | 162k | $9.2M | -1% | Mar 2026 |
|
| Federated Investors | 162k | $9.2M | -46% | Mar 2026 |
|
| CWM | 160k | $9.0M | 84% | Mar 2026 |
|
| Diadema Partners | 148k | $8.4M | 1% | Mar 2026 |
|
| Hsbc Holdings | 148k | $8.4M | -70% | Mar 2026 |
|
| SG Americas Securities | 147k | $8.3M | -59% | Mar 2026 |
|
| Jane Street | 144k | $8.1M | -63% | Mar 2026 |
|
| Covea Finance | 141k | $8.0M | 0% | Jun 2026 |
|
| Sphera Funds Management | 140k | $7.9M | -5% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 134k | $7.6M | -2% | Mar 2026 |
|
| Illinois Municipal Retirement Fund | 133k | $7.5M | -23% | Mar 2026 |
|
| KBC Group NV | 127k | $7.2M | -25% | Mar 2026 |
|
| Barclays | 123k | $6.9M | -63% | Mar 2026 |
|
| State of Wisconsin Investment Board | 122k | $6.9M | 4% | Mar 2026 |
|
| Prudential Financial | 120k | $6.8M | -18% | Mar 2026 |
|
| American Century Companies | 116k | $6.5M | 146% | Mar 2026 |
|
| Nordea Investment Management Ab | 114k | $6.3M | 100% | Mar 2026 |
|
| Creative Planning | 113k | $6.4M | 67% | Mar 2026 |
|
| Great-West Life Assurance Company | 112k | $6.3M | 1% | Mar 2026 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 109k | $6.2M | 37% | Mar 2026 |
|
| New York State Teachers Retirement System | 107k | $6.1M | 2% | Jun 2026 |
|
| Rice Hall James & Associates | 105k | $5.9M | 4% | Mar 2026 |
|
| Continuum Advisory | 105k | $5.9M | 3% | Mar 2026 |
|
| Victory Capital Management | 103k | $5.8M | -24% | Mar 2026 |
|
| Walleye Trading | 101k | $5.7M | 67% | Mar 2026 |
|
| MetLife Investment Advisors | 101k | $5.7M | 1% | Mar 2026 |
|
| Mutual Of America Capital Management | 98k | $5.5M | 23% | Mar 2026 |
|
| Vanguard Global Advisers | 98k | $5.5M | 100% | Mar 2026 |
|
| New York State Common Retirement Fund | 96k | $5.4M | 0% | Mar 2026 |
|
| APG All Pensions Group NV | 95k | $4.7M | -1% | Mar 2026 |
|
| XTX Topco | 94k | $5.3M | 852% | Mar 2026 |
|
| Privium Fund Management B.V. | 92k | $5.2M | 100% | Mar 2026 |
|
| State of Tennessee, Treasury Department | 91k | $5.2M | 0% | Mar 2026 |
|
| SummitTX Capital | 91k | $5.1M | 130% | Mar 2026 |
|
| Horizon Investments | 86k | $4.9M | -14% | Mar 2026 |
|
| Y-Intercept | 78k | $4.4M | -27% | Mar 2026 |
|
| Rafferty Asset Management | 78k | $4.4M | -31% | Mar 2026 |
|
| Ing Investment Management | 74k | $4.2M | -31% | Mar 2026 |
|
| Schroder Investment Management Group | 56k | $3.2M | -66% | Mar 2026 |
|
| Caxton Associates | 49k | $2.8M | -68% | Mar 2026 |
|
| Acadian Asset Management | 38k | $2.2M | -78% | Mar 2026 |
|
| Worldquant Millennium Quantitative Strategies | 35k | $2.0M | -92% | Mar 2026 |
|
| Edgestream Partners | 34k | $1.9M | -73% | Mar 2026 |
|
| Pacer Advisors | 24k | $1.3M | -97% | Mar 2026 |
|
| Tudor Investment Corporation | 15k | $836k | -91% | Mar 2026 |
|
| Thornburg Investment Management | 11k | $599k | -88% | Mar 2026 |
|
Who sold out of BioMarin Pharmaceutical?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Norges Bank Investment Management | Dec 2025 | 7.5M | $448M |
| Arrowstreet Capital, Limited Partnership | Dec 2025 | 850k | $51M |
| Voloridge Investment Management | Dec 2025 | 445k | $26M |
| Candriam Luxembourg S.C.A. | Dec 2025 | 408k | $24M |
| Moore Capital Management | Dec 2025 | 325k | $19M |
| Marshall Wace | Dec 2025 | 311k | $19M |
| Tredje AP-fonden | Dec 2025 | 272k | $16M |
| Schonfeld Strategic Advisors | Dec 2025 | 257k | $15M |
| ExodusPoint Capital Management | Dec 2025 | 192k | $11M |
| Steadfast Capital Management | Dec 2025 | 168k | $10M |
| Natixis | Dec 2025 | 131k | $7.8M |